Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring bla(KPC) in a one-compartment pharmacokinetic/pharmacodynamic model

Por Barber, Katie E, Pogue, Jason M, Warnock, Henderson D, Bonomo, Robert A, Kaye, Keith S
Publicado no J Antimicrob Chemother (2018)

Time–Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients

Por Rac, Hana, Stover, Kayla R., Wagner, Jamie L., King, S. Travis, Warnock, Henderson D., Barber, Katie E.
Publicado no Infect Dis Ther (2017)